antirheumatic drug

All patients in the group were receiving disease-modifying antirheumatic drugs and were clinically stable.

The drug is investigational and at present the final position within the broad set of antirheumatic drugs and its long-term safety are unknown.

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed.

Five-year follow-up of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year.

Most patients begin treatment with a DMARD (disease-modifying antirheumatic drug).

Some experts prefer to call them slow-acting antirheumatic drugs (SAARDs).

Some disease-modifying antirheumatic drugs (DMARDs) that have been around for decades.

It is known as a disease-modifying antirheumatic drug (DMARD).

Disease-modifying antirheumatic drugs (DMARDs) are usually started within 3 months of your diagnosis.

Disease-modifying antirheumatic drugs (DMARDs) slow or halt the progress of the disease.

Antimalarials are used either alone or in combination with other disease-modifying antirheumatic drugs (DMARDs).

Anakinra is used to treat the symptoms of moderate to severe rheumatoid arthritis in patients who have had an inadequate response to one or more antirheumatic drugs.

To protect joints from damage, doctors turn to disease-modifying antirheumatic drugs (DMARDs).

It belongs to a class of medications known as disease-modifying antirheumatic drugs (DMARDs).

For many patients, the pain and joint destruction the disease causes can be managed with medications such as disease-modifying antirheumatic drugs, anti-inflammatory drugs, and steroids.

Also, disease-modifying antirheumatic drugs (DMARDs) such as methotrexate may be helpful.

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

Cyclophosphamide is a disease-modifying antirheumatic drug (DMARD), which means it controls the progression of the disease.

Biologics - and other disease-modifying antirheumatic drugs (DMARDs) - have revolutionized the approach.

Medicines called disease-modifying antirheumatic drugs (DMARDs) can slow or sometimes prevent joint destruction.

Discussion Currently, MTX is the most widely used disease-modifying antirheumatic drug for the treatment of RA.

Methotrexate and etanercept are disease-modifying antirheumatic drugs (DMARDs).

Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, which can help relieve joint pain and dry skin.

Disease-modifying antirheumatic drugs (DMARD) are the primary treatment for RA.

Gold is not usually the first treatment given to people with rheumatoid arthritis, since methotrexate and other disease-modifying antirheumatic drugs (DMARDs) are available.